Oberweis Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-292,871
Closed -$5.72M 187
2025
Q2
$5.72M Sell
292,871
-130,400
-31% -$2.32M 0.25% 134
2025
Q1
$7.51M Sell
423,271
-200
-0% -$4.31K 0.37% 99
2024
Q4
$9.07M Buy
423,471
+128,971
+44% +$3.14M 0.43% 88
2024
Q3
$9.2M Buy
294,500
+44,100
+18% +$1.1M 0.47% 83
2024
Q2
$3.89M Buy
+250,400
New +$3.03M 0.24% 140
2021
Q4
Sell
-47,850
Closed -$3.03M 157
2021
Q3
$3.03M Buy
47,850
+1,020
+2% +$77.7K 0.63% 20
2021
Q2
$4.29M Sell
46,830
-19,010
-29% -$1.51M 0.94% 18
2021
Q1
$4.48M Sell
65,840
-57,400
-47% -$4.46M 0.92% 18
2020
Q4
$8.93M Buy
123,240
+4,340
+4% +$251K 2.35% 6
2020
Q3
$4.51M Buy
118,900
+32,150
+37% +$1.09M 1.52% 11
2020
Q2
$3.07M Buy
+86,750
New +$2.47M 1.21% 13
2019
Q4
Sell
-244,410
Closed -$5.53M 205
2019
Q3
$5.53M Sell
244,410
-12,050
-5% -$334K 1.25% 20
2019
Q2
$9.23M Buy
256,460
+47,250
+23% +$1.51M 1.68% 11
2019
Q1
$6.59M Buy
209,210
+156,910
+300% +$4.57M 1.32% 20
2018
Q4
$1.31M Hold
52,300
0.29% 59
2018
Q3
$1.51M Buy
+52,300
New +$979K 0.29% 57

Other funds holding CDNA

Oberweis Asset Management's CDNA Position: Q3 2025 in Review

Oberweis Asset Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 292,871 shares — an estimated $5.72M sold.

Oberweis Asset Management first reported a position in CDNA in Q3 2018 and held it in 16 quarters. The position peaked at $9.23M in Q2 2019. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Oberweis Asset Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Oberweis Asset Management sold 292,871 CareDx shares in Q3 2025, an estimated $5.72M.
  • Oberweis Asset Management first reported a position in CareDx in Q3 2018 and held it in 16 quarters.
  • Oberweis Asset Management's CareDx position peaked at $9.23M in Q2 2019.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Oberweis Asset Management's 13F filing for Q3 2025, filed 17 Nov 2025.